Toronto Dominion Bank’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-56,291
| Closed | -$5.72M | – | 2212 |
|
|
2025
Q4 | $5.72M | Buy |
+56,291
| New | +$4.52M | 0.01% | 809 |
|
|
2025
Q3 | – | Sell |
-272
| Closed | -$14.5K | – | 1976 |
|
|
2025
Q2 | $14.5K | Sell |
272
-27,549
| -99% | -$1.4M | ﹤0.01% | 1606 |
|
|
2025
Q1 | $1.2M | Buy |
27,821
+2,675
| +11% | +$135K | ﹤0.01% | 1044 |
|
|
2024
Q4 | $1.41M | Buy |
25,146
+1,518
| +6% | +$94.5K | ﹤0.01% | 1001 |
|
|
2024
Q3 | $1.61M | Buy |
23,628
+5,831
| +33% | +$329K | ﹤0.01% | 793 |
|
|
2024
Q2 | $752K | Sell |
17,797
-553
| -3% | -$30.4K | ﹤0.01% | 934 |
|
|
2024
Q1 | $1.27M | Sell |
18,350
-6,241
| -25% | -$395K | ﹤0.01% | 849 |
|
|
2023
Q4 | $1.82M | Sell |
24,591
-10,924
| -31% | -$716K | ﹤0.01% | 878 |
|
|
2023
Q3 | $2.42M | Sell |
35,515
-8,363
| -19% | -$710K | ﹤0.01% | 838 |
|
|
2023
Q2 | $4.12M | Sell |
43,878
-5,337
| -11% | -$416K | 0.01% | 750 |
|
|
2023
Q1 | $3.33M | Sell |
49,215
-4,119
| -8% | -$265K | 0.01% | 774 |
|
|
2022
Q4 | $2.64M | Buy |
53,334
+14,777
| +38% | +$604K | ﹤0.01% | 842 |
|
|
2022
Q3 | $1.25M | Sell |
38,557
-293
| -0.8% | -$12.1K | ﹤0.01% | 1025 |
|
|
2022
Q2 | $1.53M | Buy |
38,850
+1,948
| +5% | +$104K | ﹤0.01% | 799 |
|
|
2022
Q1 | $2.58M | Buy |
36,902
+2,990
| +9% | +$219K | ﹤0.01% | 720 |
|
|
2021
Q4 | $2.64M | Buy |
33,912
+11,514
| +51% | +$1.02M | ﹤0.01% | 766 |
|
|
2021
Q3 | $2.14M | Sell |
22,398
-431
| -2% | -$45.5K | ﹤0.01% | 738 |
|
|
2021
Q2 | $2.84M | Buy |
22,829
+1,337
| +6% | +$160K | ﹤0.01% | 681 |
|
|
2021
Q1 | $2.83M | Sell |
21,492
-8,403
| -28% | -$1.15M | 0.01% | 673 |
|
|
2020
Q4 | $3.96M | Buy |
29,895
+4,833
| +19% | +$584K | 0.01% | 644 |
|
|
2020
Q3 | $2.56M | Buy |
25,062
+2,536
| +11% | +$219K | 0.01% | 683 |
|
|
2020
Q2 | $1.96M | Buy |
22,526
+2,504
| +13% | +$200K | 0.01% | 730 |
|
|
2020
Q1 | $1.16M | Sell |
20,022
-5,184
| -21% | -$421K | ﹤0.01% | 736 |
|
|
2019
Q4 | $2.33M | Buy |
25,206
+4,456
| +21% | +$392K | ﹤0.01% | 720 |
|
|
2019
Q3 | $1.88M | Sell |
20,750
-17,628
| -46% | -$2.01M | ﹤0.01% | 837 |
|
|
2019
Q2 | $2.27M | Buy |
+38,378
| New | +$3.87M | ﹤0.01% | 806 |
|
|
2019
Q1 | – | Sell |
-26
| Closed | -$2K | – | 1604 |
|
|
2018
Q4 | $2K | Buy |
+26
| New | +$1.78K | ﹤0.01% | 1390 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Toronto Dominion Bank's EXAS Position: Q1 2026 in Review
Toronto Dominion Bank sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 56,291 shares — an estimated $5.72M sold.
Toronto Dominion Bank first reported a position in EXAS in Q4 2018 and held it in 27 quarters. The position peaked at $5.72M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Toronto Dominion Bank reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Toronto Dominion Bank sold 56,291 Exact Sciences shares in Q1 2026, an estimated $5.72M.
- Toronto Dominion Bank first reported a position in Exact Sciences in Q4 2018 and held it in 27 quarters.
- Toronto Dominion Bank's Exact Sciences position peaked at $5.72M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.